1. Home
  2. CACI vs RGEN Comparison

CACI vs RGEN Comparison

Compare CACI & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CACI International Inc.

CACI

CACI International Inc.

HOLD

Current Price

$567.65

Market Cap

12.9B

Sector

Technology

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$160.33

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CACI
RGEN
Founded
1962
1981
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.9B
8.2B
IPO Year
1979
N/A

Fundamental Metrics

Financial Performance
Metric
CACI
RGEN
Price
$567.65
$160.33
Analyst Decision
Buy
Buy
Analyst Count
14
10
Target Price
$616.50
$170.90
AVG Volume (30 Days)
236.7K
724.0K
Earning Date
01-21-2026
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
12.06
N/A
EPS
22.62
0.03
Revenue
$8,858,558,000.00
$707,890,000.00
Revenue This Year
$10.71
$17.84
Revenue Next Year
$6.15
$12.57
P/E Ratio
$25.30
$6,185.26
Revenue Growth
12.61
11.74
52 Week Low
$318.60
$102.97
52 Week High
$632.77
$182.52

Technical Indicators

Market Signals
Indicator
CACI
RGEN
Relative Strength Index (RSI) 39.74 51.46
Support Level $583.84 $156.31
Resistance Level $603.75 $165.02
Average True Range (ATR) 17.55 4.73
MACD -6.28 -1.26
Stochastic Oscillator 4.32 24.04

Price Performance

Historical Comparison
CACI
RGEN

About CACI CACI International Inc.

CACI International Inc is an information solutions and services provider, offering information solutions and services to its customers. The company's primary customers are agencies and departments of the U.S. government, which account for the vast majority of the firm's revenue. It provides information solutions and services supporting national security missions and government modernization for intelligence, defense, and federal civilian customers. Some of the services provided by the company are functional software development, data, and business analysis, IT operations support, naval architecture, and life cycle support intelligence among others. The company's operating segments are; Domestic operations and International operations. It derives key revenue from the Domestic segment.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: